Ron Baron Comments on IDEXX Laboratories

Guru stock highlight

Author's Avatar
Apr 25, 2017

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) rose in the first quarter, rallying on strong financial results and multiple expansion. Competitive trends are strong and improving, highlighted by instrument revenue growth, domestic lab growth, rising sales productivity, and stability in rapid assays. We think that IDEXX’s direct go-to-market model coupled with meaningful research and development-driven product enhancements will put steady upward pressure on organic revenue and earnings growth over time. (Neal Rosenberg)

From Ron Baron (Trades, Portfolio)'s first quarter 2017 Baron Partners Fund commentary.